Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Checkpoint inhibitors and aspergillosis in AML: the double hit hypothesis.

× No keyword cloud information.

6 in total

Review 1. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors).

Authors: G Redelman-Sidi; O Michielin; C Cervera; C Ribi; J M Aguado; M Fernández-Ruiz; O Manuel
Journal: Clin Microbiol Infect Date: 2018-02-07 Impact factor: 8.067

Review 2. Aspergillus fumigatus and Aspergillosis in 2019.

Authors: Jean-Paul Latgé; Georgios Chamilos
Journal: Clin Microbiol Rev Date: 2019-11-13 Impact factor: 26.132

Review 3. Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML.

Authors: Anne Sophie Kubasch; Uwe Platzbecker
Journal: Cancers (Basel) Date: 2018-05-24 Impact factor: 6.639

Review 4. Emerging Fungal Infections: New Patients, New Patterns, and New Pathogens.

Authors: Daniel Z P Friedman; Ilan S Schwartz
Journal: J Fungi (Basel) Date: 2019-07-20

5. Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis.

Authors: Sebastian Wurster; Nathaniel D Albert; Uddalak Bharadwaj; Moses M Kasembeli; Jeffrey J Tarrand; Naval Daver; Dimitrios P Kontoyiannis
Journal: Front Immunol Date: 2022-02-18 Impact factor: 7.561

Review 6. New hematologic populations at risk of invasive aspergillosis: focus on new targeted, biological, and cellular therapies.

Authors: Corrado Girmenia
Journal: F1000Res Date: 2019-07-26

6 in total